2nd Time Around on Clubhouse

Description

The focus of this club is harnessing the power of drug repurposing. We will discuss studies investigating the use of existing drugs for new medical purposes, such as the treatment of cancer, rare diseases, and COVID-19.

🔶🔸🔶🔸🔸🔶🔸🔶🔸🔶🔸🔸🔶🔸🔶
🔸🔶🔸🔶Suggested Reading🔶🔸🔶🔸 🔸🔶🔸🔶Past/Upcoming topics🔶🔸🔶🔸
🔶🔸🔶🔸🔸🔶🔸🔶🔸🔶🔸🔸🔶🔸🔶
July 11 (phospholipidosis):
📔Tummimo TA, et al. (2021). Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2. Science 22 Jun 2021: eabi4708 DOI: 10.1126/science.abi4708 📔Also see Dr. Reiersen’s Twitter Feed (info about upcoming rooms & suggested reading pinned at top of feed).


🔶TBA Possible Future Topics🔶
If you have particular interest in one of these these topics (as a moderator, panelist, or listener), or if you suggest other topics, message Dr. Reiersen or Dr. Ocean on Instagram or Twitter.
🔸Drug repurposing for cancer
🔸Drug repurposing for rare diseases
🔸Drug repurposing for psychiatric conditions
🔸Drug repurposing for COVID-19
🔸Discussion of current COVID trials listed on clinicaltrials.gov
🔸Discussion of new COVID treatment articles

🗄🗄🗄🗄🗄🗄🗄🗄🗄🗄🗄🗄🗄🗄🗄
🗄PAST ROOMS & RELEVANT READING🗄
🔸Sunday April 25, 5PM CT:🔸
Fluvoxamine Mechanisms in Treatment of COVID-19
📔📔Suggested reading📔📔
(in order of importance to topic)
📔Sukhatme VP, et al. Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19. Front. Pharmacol., 20 April 2021. Available at: https://www.frontiersin.org/articles/10.3389/fphar.2021.652688/full

⚠️⚠️⚠️⚠️Disclaimer⚠️⚠️⚠️⚠️
Nothing discussed in this club
should be considered medical advice.
If you are in need of medical care,
please consult your own physician.
🔆🔅🔆🔅🔆🔅🔆🔅🔆🔅🔆🔅🔆🔅 ⚠️⚠️⚠️OFF-LABEL USE ALERT⚠️⚠️⚠️
Please note that many of the treatments discussed in this club are being investigated for new uses, so safety and efficacy may not have been established. In most cases these treatments are NOT FDA APPROVED for the purposes discussed.